Tessa Therapeutics' Unattributed Round

Tessa Therapeutics raised a round of funding on December 20, 2017.

Tessa Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of cancer immunotherapies.…

Articles about Tessa Therapeutics' Unattributed Round: